Elevation Oncology Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Millions EGP. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2020
Net Income	209.63	176.59	148.09	128.88	127.19	121.26	Upgrade
Other Operating Activities	-36.24	-3.18	39.75	-17.93	-16.2	-9.21	Upgrade
Operating Cash Flow	173.39	173.41	187.83	110.95	110.99	112.05	Upgrade
Operating Cash Flow Growth	-7.69%	-7.68%	69.29%	-0.03%	-0.95%	37.10%	Upgrade
Capital Expenditures	-42.77	-42.8	-70.48	-35.94	-14.56	-12.71	Upgrade
Sale of Property, Plant & Equipment	2.33	2.33	0.09	0.81	0.16	0.35	Upgrade
Investing Cash Flow	-40.44	-40.48	-70.39	-35.14	-14.4	-12.35	Upgrade
Common Dividends Paid	-134.41	-134.39	-110.31	-80.84	-90.91	-106.98	Upgrade
Financing Cash Flow	-134.41	-134.39	-110.31	-80.84	-90.91	-106.98	Upgrade
Net Cash Flow	-1.46	-1.46	7.13	-5.02	5.68	-7.28	Upgrade
Free Cash Flow	130.62	130.61	117.35	75.01	96.43	99.35	Upgrade
Free Cash Flow Growth	11.28%	11.29%	56.45%	-22.22%	-2.93%	31.13%	Upgrade
Free Cash Flow Margin	15.98%	18.27%	18.91%	14.27%	18.91%	19.50%	Upgrade
Free Cash Flow Per Share	21.77	21.77	19.56	12.50	16.07	16.56	Upgrade
Cash Income Tax Paid	28.97	28.98	17.66	15.35	17.22	26.84	Upgrade
Levered Free Cash Flow	-174.58	77.62	-85.11	113.84	88.73	-33.66	Upgrade
Unlevered Free Cash Flow	-174.58	77.62	-85.11	113.84	88.73	-33.66	Upgrade
Change in Net Working Capital	204.13	-63.22	75.81	-96.66	-52.1	59.43	Upgrade

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.